Although Astrazeneca News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bargains abound with the innovation-driven Nasdaq Composite still well below its all-time high.

A new analysis examined deaths in Britain, where the company’s product was restricted in 2021 because of safety concerns.

Events I think that could send AstraZeneca shares rallying in 2021 More on: Although AstraZeneca(LSE:AZN) shares didn’t decline in 2020, they haven’t rallied like many other FTSE 100 stocks have in the past three months either. One reason could be that some of the potentially positive events for AZN in 2020 didn’t turn out to be as great as expected.  Many investors, for example, regarded AstraZeneca’s Covid-19 vaccine as one of the leaders for much of its development phase. When it came to end results, however, AstraZeneca’s Covid-19 vaccine efficacy rate wasn’t as great as ...

What I think AstraZeneca’s purchase of Alexion means for the dividend More on: AstraZeneca(LSE:AZN) recently agreed to buy Alexion Pharmaceuticals for around $39bn. Although management has spoken positively about the deal, AstraZeneca shares initially fell 5.7% to a nine-month low on the news. Given the initial market reaction, here’s what I think the deal means for AstraZeneca’s dividend if it goes through: US$12.3 TRILLION out of thin air… And if you click here we’ll show you something that could be key to unlocking 5G’s full potential... The reaction to the Alexion deal  Ac...